RLLFT-NH2
TFLLR-NH2 is a reversed-sequence peptide agonist selectively targeting protease-activated receptor 1 (PAR1) . It is utilized in research to study PAR1-mediated signaling in vitro and has been shown to elevate pain thresholds in vivo, making it a tool for investigating nociception and thrombosis.
Product Specifications
Molecular Weight
647.81
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog